{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-004957","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2025-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.980440+00:00","generated_at":"2026-05-26T14:14:11.856155+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GNI Group FY2024 revenue down 9.2%, operating profit plunges 89.3%; Gyre pipeline catalysts set for 2025","bullets":["Revenue ¥23,611M (-9.2% YoY); operating profit ¥1,402M (-89.3%); pre-tax profit ¥238M (-98.1%).","Net loss attributable to owners of parent ¥977M (vs. ¥8,094M profit in FY2023); basic EPS ¥19.55 (vs. ¥169.50).","Operating cash flow negative ¥3,164M; investing cash outflow ¥10,361M; cash position ¥10,115M.","Gyre Pharms: Hydronidone Phase 3 topline data expected Q1 2025; F573 Ph2 completion, F230 Ph1 start planned.","F528 IND submission targeted for Dec 2025; GNI Group forecasts FY2025 revenue ¥28,733M (+21.7% YoY)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-004957","json":"https://secwatch.observer/filing/0001140361-25-004957.json","markdown":"https://secwatch.observer/filing/0001140361-25-004957.md","text":"https://secwatch.observer/filing/0001140361-25-004957.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125004957/0001140361-25-004957-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125004957/ny20043721x1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T14:14:11.856155+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}